Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-03-16 @ 1:45 AM
Study NCT ID:
NCT03580694
Status:
TERMINATED
Last Update Posted:
2020-03-13
First Post:
2018-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of REGN4659 in Combination With Cemiplimab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-27
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-04
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-26
First Submit QC Date:
None
Study First Post Date:
2018-07-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-11
Last Update Post Date:
2020-03-13
Last Update Post Date Type:
ACTUAL